GlassScriptPhysician profile
Kimberly Galgano
NPI 1689658502
$870.20
in general payments reported to CMS, 2019-2025
15 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.82 · 2020: $36.95 · 2021: $92.58 · 2022: $200 · 2023: $320 · 2024: $61.20 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $485.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $343.71 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $118.64 | 2021-2025 | |
| Astellas Pharma US INC | $66.69 | 2023-2024 | Veozah |
| Sumitomo Pharma America, INC. | $51.56 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $44.81 | 2021-2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $44.55 | 2022 | |
| Pfizer INC. | $34.37 | 2023-2024 | |
| Therapeuticsmd, INC. | $31.66 | 2019-2020 | |
| Ethicon US, LLC | $25.48 | 2023 | Vistaseal, Ethicon |
| Abbott Laboratories | $22.48 | 2023 | Freestyle Libre 3 |
| Coopersurgical, INC. | $21.44 | 2025 | Endosee, Paragard T 380a |
| Amag Pharmaceuticals, INC. | $19.02 | 2019 | |
| Myovant Sciences INC. | $16.48 | 2022 | |
| Renovia INC | $14.94 | 2021 | |
| Hologic Sales and Service, LLC | $14.37 | 2024 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Galgano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.